Intelligence · Clinical Pipeline
LEXICON PHARMACEUTICALS Pipeline
All ClinicalTrials.gov programs at LEXICON PHARMACEUTICALS — phase, modality, and trial IDs.
- Programs
- 12
Quick answer
LEXICON PHARMACEUTICALS has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
PLACEBO SOTAGLIFLOZIN, SOTAGLIFLOZIN
LEXICON PHARMACEUTICALS, INC.
Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
1 trial -
Placebo
LEXICON PHARMACEUTICALS, INC.
Type 2 Diabetes Mellitus
2 trials -
Placebo
LEXICON PHARMACEUTICALS, INC.
Type 1 Diabetes Mellitus
2 trials -
Sotagliflozin
LEXICON PHARMACEUTICALS, INC.
Heart Failure
2 trials -
Sotagliflozin
LEXICON PHARMACEUTICALS, INC.
Diabetic Nephropathies
1 trial -
Sotagliflozin
LEXICON PHARMACEUTICALS, INC.
Type 1 Diabetes Mellitus
3 trials -
Sotagliflozin
LEXICON PHARMACEUTICALS, INC.
Type 1 Diabetes Mellitus (T1DM)
1 trial -
Sotagliflozin
LEXICON PHARMACEUTICALS, INC.
Type 2 Diabetes Mellitus
3 trials -
Sotagliflozin
LEXICON PHARMACEUTICALS, INC.
Obstructive Cardiomyopathy, Hypertrophic
1 trial -
Sotagliflozin (SAR439954)
LEXICON PHARMACEUTICALS, INC.
Type 2 Diabetes Mellitus
4 trials -
Sotagliflozin Low Dose
LEXICON PHARMACEUTICALS, INC.
Type 1 Diabetes (T1D)
1 trial -
Telotristat etiprate
LEXICON PHARMACEUTICALS, INC.
Carcinoid Syndrome
5 trials
Frequently asked questions
How many pipeline programs does LEXICON PHARMACEUTICALS have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs